UBS lowered the firm’s price target on Corteva (CTVA) to $85 from $91 and keeps a Buy rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Apple downgraded, Alibaba upgraded: Wall Street’s top analyst calls
- Corteva downgraded to Sector Weight from Overweight at KeyBanc
- Nike upgraded, RH downgraded: Wall Street’s top analyst calls
- Corteva’s Strategic Split: Unlocking Shareholder Value with a Buy Rating
- Corteva’s Strategic Spin-Off and Market Challenges: A Hold Rating Amid Investor Concerns